Rowley J, Vander Hoorn SV, Korenromp E, Low N, Unemo M, Abu-Raddad LJ, et al. Chlamydia, gonorrhoea, trichomoniasis and syphilis: global prevalence and incidence estimates, 2006. Bull World Health Organ. 2016;97:548–62.
Korzeniewski K. Sexually transmitted infections among army personnel in the military environment. Sex Trans Infect. 2012;71:165–82.
Gaydos JC, McKee KT, Faix DJ. Sexually transmitted infections in the military: new challenges for an old problem. Sex Transm Infect. 2015;91:536–7.
Google Scholar
Horner P, Donders G, Cusini M, Gomberg M, Jensen JS, Unemo M. Should we be testing for urogenital Mycoplasma hominis, Ureaplasma parvum and Ureaplasma urealyticum in men and women?—A position statement from the European STI Guidelines Editorial Board. JEADV. 2018;32:1845–51.
Google Scholar
Mielczarek E, Blaszkowska J. Trichomonas vaginalis: pathogenicity and potential role in human reproductive failure. Infection. 2016;44:447–58.
Google Scholar
Cotch MF, Pastorek JG 2nd, Nugent RP, Hillier SL, Gibbs RS, Martin DH, et al. Trichomonas vaginalis associated with low birth weight and preterm delivery. The Vaginal Infections and Prematurity Study Group. Sex Transm Dis. 1997;24:353–60.
Google Scholar
Fichorova RN. Impact of Trichomonas vaginalis on innate immune responses and reproductive outcome. J Reprod Immunol. 2009;83:185–9.
Google Scholar
Tao L, Han L, Li X, Gao Q, Pan L, Wu L, et al. Prevalence and risk factors for cervical neoplasia: a cervical cancer screening program in Beijing. BMC Public Health. 2014;14:1185.
Google Scholar
Ghosh I, Muwonge R, Mittal S, Banerjee D, Kundu P, Mandal R, et al. Association between high risk human papillomavirus infection and co-infection with Candida spp. and Trichomonas vaginalis in women with cervical premalignant and malignant lesions. J Clin Virol. 2017;87:43–8.
Google Scholar
Mercer F, Johnson PJ. Trichomonas vaginalis: pathogenesis, symbiont interactions, and host cell immune response. Trends Parasitol. 2018;34:683–93.
Google Scholar
Sutcliffe S, Giovannucci E, Alderete JF, Chang TE, Gaydos CA, Zenilman JM, et al. Plasma antibodies against Trichomonas vaginalis and subsequent risk of prostate cancer. Cancer Epidemiol Biomarkers Prev. 2015;15:939–45.
Weisburg WG, Tully JG, Rose DL, Petzel JP, Oyaizu H, Yang D, et al. A phylogenetic analysis of the mycoplasmas: basis for their classification. J Bacteriol. 1989;171:6455–67.
Google Scholar
Fichorova R, Fraga J, Rappelli P, Fiori PL. Trichomonas vaginalis infection in symbiosis with Trichomonasvirus and Mycoplasma. Research Microbiol. 2017. https://doi.org/10.1016/j.resmic.2017.03.005.
Google Scholar
Cao CJ, Wang YF, Fang DM, Hu Y. Relation between mycoplasma infection and recurrent spontaneous abortion. Eur Rev Med Pharmacol Sci. 2018;22:2207–11.
Google Scholar
Ahmadi MH, Mirsalehian A, Gilani MAS, Bahador A, Talebi M. Asymptomatic infection with Mycoplasma hominis negatively affects semen parameters and leads to male infertility as confirmed by improved semen parameters after Antibiotic treatment. Urology. 2017;100:97–102.
Google Scholar
Zeighami H, Peerayesh SN, Yazdi RS, Sorouri R. Prevalence of Ureaplasma urealyticum and Ureaplasma parvum in semen of infertile and healthy men. Int J STD AIDS. 2009;20:387–90.
Google Scholar
Gupta V, Dhawan B, Khanna N, Agarwal N, Bhattacharya SN, Sreenivas V, et al. Detection and biovar discrimination of Ureaplasma urealyticum in Indian patients with genital tract infections. Diagn Microbiol Infect Dis. 2008;60:95–7.
Google Scholar
Humburg J, Frei R, Wight E, Troeger C. Accuracy of urethral swab and urine analysis for the detection of Mycoplasma hominis and Ureaplasma urealyticum in women with lower urinary tract symptoms. Arch Gynecol Obstet. 2012;285:1049–53.
Google Scholar
Horner PJ, Martin DH. Mycoplasma genitalium infection in men. J Infect Dis. 2017;216:396–405.
STI Treatment Guidelines, 2021. https://www.cdc.gov/std/treatment-guidelines/default.htm. Accessed on 10.10.2022.
Fettweiss JM, Serrano MG, Huang B, Brooks JP, Glascock AL, Sheth NU, et al. An emerging Mycoplasma associated with trichomoniasis, vaginal infection and disease. PLoS ONE. 2014;9:e110943.
CDC. Sexually Transmitted Disease Surveillance 2012. Atlanta: U.S. Department of Health and Human Science, 2013. http://www.cdc.gov/sTD/stats12/Surv2012.pdf. Accessed on 10.10.2022.
Malhotra M, Sood S, Mukherjee A, Muralidhar S, Bala M. Genital Chlamydia trachomatis: an update. Indian J Med Res. 2013;138:303–16.
Google Scholar
Marrazzo JM, Whittington WL, Celum CL, Handsfield HH, Clark A, Cles L, et al. Urine-based screening for Chlamydia trachomatis in men attending sexually transmitted disease clinics. Sex Transm Dis. 2001;28:219–25.
Google Scholar
Todd CS, Haase C, Stoner B. Emergency department screening for asymptomatic sexually transmitted infections. Am J Public Health. 2001;91:461–4.
Google Scholar
Garnett GP, Bowden JF. Epidemiology and control of curable sexually transmitted diseases: opportunities and problems. Sex Transm Dis. 2000;27:588–99.
Google Scholar
Kengne P, Veas F, Vidal N, Rey JL, Cuny G. Trichomonas vaginalis: repeated DNA target for highly sensitive and specific polymerase chain reaction diagnosis. Cell Mol Biol. 1994;40:819–31.
Google Scholar
Van Kuppeveld FJM, Van Der Logt JTM, Angulo AF, Van Zoest MJ, Quint GV, Niesters GM, et al. Genus- and species-specific identification of mycoplasma by 16S rRNA amplification. Appl Environ Microbiol. 1992;58:2606–15.
Google Scholar
Jensen JS, Uldum SA, Søndergård-Andersen J, Vuust J, Lind K. Polymerase chain reaction for detection of Mycoplasma genitalium in clinical samples. J Clin Microbiol. 1991;29:46–50.
Google Scholar
Safarkar R, Mehrabadi JF, Noormohammadi Z, Mirnejad R. Development a rapid and accurate multiplex real time PCR method for the detection Chlamydia trachomatis and Mycoplasma hominis. J Clin Lab Anal. 2017;31:e22126.
Google Scholar
Hsu MC, Tsai PY, Chen KT, Li LH, Chiang CC, Tsai JJ, et al. Genotyping of Chlamydia trachomatis from clinical specimens in Taiwan. J Med Microbiol. 2006;55:301–8.
Google Scholar
Korzeniewski K, Juszczak D, Paul P. Sexually transmitted infections in the military environment. Int Marit Health. 2020;71:207–12.
Google Scholar
Pellrud H, Golparian D, Nilsson CS, Falk M, Fredlund H, Unemo M. Trichomonas vaginalis infections are rare among young patients attending an STI clinic in Sweden. Acta Derm Venereol. 2015;95:343–4.
Google Scholar
Hilmarsdottir I, Sigmundsdottir E, Eiriksdottir A, Golparian D, Unemo M. Trichomonas vaginalis is rare among women in Iceland. Acta Derm Venereol. 2017;97:1258–60.
Google Scholar
Chiu SF, Huang PJ, Cheng WH, Huang CY, Chu LJ, Lee CC, et al. Vaginal microbiota of the sexually transmitted infections caused by Chlamydia trachomatis and Trichomonas vaginalis in women with vaginitis in Taiwan. Microorganisms. 2021;9:1864. https://doi.org/10.3390/microorganisms9091864.
Google Scholar
Sena AC, Miller WC, Hobbs MM, Schwebke JR, Leone PA, Swygard H, et al. Trichomonas vaginalis infection in male sexual partners: implications for diagnosis, treatment, and prevention. Clin Infect Dis. 2007;44:13–22.
Google Scholar
Joo CY, Choi DW. Prevalence of Trichomonas vaginalis in Korean military Personnel. Kisaengchunghak Chapchi. 1980;18:247–52.
Google Scholar
McKee KT Jr, Jenkins PR, Garner R, Jenkins RA, Nannis ED, Hoffman IF, et al. Features of urethritis in a cohort of male soldiers. Clin Infect Dis. 2000;30:736–41.
Google Scholar
Christofolini DM, Leuzzi L, Mafra FA, Rodart I, Kayaki EA, Bianco B, et al. Prevalence of cases of Mycoplasma hominis, Mycoplasma genitalium, Ureaplasma urealyticum and Chlamydia trachomatis in women with no gynecologic complaints. Reprod Med Biol. 2012;11:201–5.
Google Scholar
Bautista CT, Wurapa EK, Sateren WB, Hollingsworth BP, Sanchez JL. Longitudinal association of gonorrhea and bacterial vaginosis with repeat chlamydia diagnoses among U.S. Army women: a retrospective cohort analysis. Mil Med Res. 2018;5:37.
Google Scholar
Van Der Pol B. Clinical and laboratory testing for Trichomonas vaginalis infection. J Clin Microbiol. 2016;54:7–12.
Workowski KA, Bolan GA. Sexually transmitted diseases treatment guidelines. MMWR Recomm Rep. 2015;64:1–137.
Google Scholar
Donders GG, Vieira-Baptista P. Bacterial vaginosis and inflammatory response showed association with severity of cervical neoplasia in HPV-positive women. Diagn Cytopathol. 2017;45:472–3.
Google Scholar
Cox C, Saxena N, Watt AP, Gannon C, McKenna JP, Fairley DJ, et al. The common vaginal commensal bacterium Ureaplasma parvum is associated with chorioamnionitis in extreme preterm labor. J Matern Fetal Neonatal Med. 2016;29:3646–51.
Google Scholar
Taylor-Robinson D, Lamont RF. Mycoplasmas in pregnancy. BJOG. 2011;118:164–74.
Google Scholar
Safari M, Bakhshi A, Erami M, Kheirkhah B, Pourbakhsh A, Pourbabei H. Sequences of Mycoplasma hominis in patients with urinary tract infection in a hospital in Kashan, Iran. Res J Microbiol. 2015;10:260–9.
Lee MY, Kim MH, Lee WI, Kang SY, La JY. Prevalence and antibiotic susceptibility of Mycoplasma hominis and Ureaplasma urealyticum in pregnant women. Int J Infect Dis. 2010;57:90–5.
Choi JB, Lee SJ, Lee MK, Lee SJ, Park DC, Kim HY, et al. Prevalence and antimicrobial susceptibility of Ureaplasma spp. and Mycoplasma hominis in asymptomatic individuals in Korea. Microb Drug Resist. 2018;24:1391–6.
Google Scholar
Chandeying V, Skov S, Duramad P, Makepeace B, Ward M, Khunigij P. The prevalence of urethral infections amongst asymptomatic young men in Hat Yai, southern Thailand. Int J STD AIDS. 2000;11:402–5.
Google Scholar
Gupta V, Dhawan B, Khanna N, Agarwal N, Bhattacharya SN, Sreenivas V, et al. Detection and biovar discrimination of Ureaplasma urealyticum in Indian patients with genital tract infection. Diagn Microbiol Infect Dis. 2008;60:95–7.
Google Scholar
Kasprzykowska U, Sobieszczanska B, Duda-Madej A, Secewicz A, Nowicka J, Gosciniak G. A twelve-year retrospective analysis of prevalence and antimicrobial susceptibility patterns of Ureaplasma spp. and Mycoplasma hominis in the province of lower Silesia in Poland. Eur J Obstet Gynecol Reprod Biol. 2018;220:44–9.
Google Scholar
Hata A, Honda Y, Asada K, Sasaki Y, Kenri T, Hata D. Mycoplasma hominis meningitis in a neonate: case report and review. J Infect. 2008;57:338–43.
Google Scholar
Saadat S, Karami P, Jafari M, Kholoujini M, Rikhtegaran Tehrani Z, Mohammadi Y, et al. The silent presence of Mycoplasma hominis in patients with prostate cancer. Pathog Dis. 2020;78:ftaa037. https://doi.org/10.1093/femspd/ftaa037.
Google Scholar
Al-Sweih NA, Al-Fadli AH, Omu AE, Rotimi VO. Prevalence of Chlamydia trachomatis, Mycoplasma hominis, Mycoplasma genitalium, and Ureaplasma urealyticum infections and seminal quality in infertile and fertile men in Kuwait. J Androl. 2012;33:1323–9.
Google Scholar
Arya OP, Tong CY, Hart CA, Pratt BC, Hughes S, Roberts P, et al. Is mycoplasma hominis a vaginal pathogen? Sex Transm Infect. 2001;77:58–62.
Google Scholar
Horner P, Donders G, Cusini M, Gomberg M, Jensen JS, Unemo M. Should we be testing for urogenital Mycoplasma hominis, Ureaplasma parvum and Ureaplasma urealyticum in men and women?—a position statement from the European STI Guidelines Editorial Board. J Eur Acad Dermatol Venereol. 2018;32:1845–51.
Google Scholar
Gdoura R, Kchaou W, Chaari C, Znazen A, Keskes L, Rebai T, et al. Ureaplasma urealyticum, Ureaplasma parvum, Mycoplasma hominis and Mycoplasma genitalium infections and semen quality of infertile men. BMC Inf Dis. 2007;7:129. https://doi.org/10.1186/1471-2334-7-129.
Google Scholar
Martin DH, Zozaya M, Lillis RA, Myers L, Nsuami MJ, Ferris MJ. Unique vaginal microbiota that includes an unknown Mycoplasma-like organism is associated with Trichomonas vaginalis infection. J Infect Dis. 2013;207:1922–31.
Google Scholar
Allen-Daniels MJ, Serrano MG, Pflugner LP, Fettweis JM, Prestosa MA, Koparde VN, et al. Identification of a gene in Mycoplasma hominis associated with preterm birth and microbial burden in intraamniotic infection. Am J Obstet Gynecol. 2015;212:e1-79.e13.
Morency P, Dubois MJ, Gresenguet G. Aetiology of urethral discharge in Bangui, Central African Republic. Sex Transm Inf. 2001;77:125–9.
Andersen B, Sokolowski A, Østergaard L, Kjłlseth Młller J, Olesen F, Jensen JS. Mycoplasma genitalium: prevalence and behavioural risk factors in the general population. Sex Transm Infect. 2007;83:237–41.
Google Scholar
Baumann L, Cina M, Egli-Gany D, Goutaki M, Halbeisen FS, Lohrer GR, et al. Prevalence of Mycoplasma genitalium in different population groups: systematic review and meta-analysis. Sex Transm Infect. 2018;94:255–62.
Google Scholar
Gottesman T, Yossepowitch O, Samra Z, Rosenberg S, Dan M. Prevalence of Mycoplasma genitalium in men with urethritis and in high risk asymptomatic males in Tel Aviv: a prospective study. Int J STD AIDS. 2017;28:127–32.
Google Scholar
Tjagur S, Mandar R, Punab M. Prevalence of Mycoplasma genitalium and other sexually transmitted infections causing urethritis among high-risk heterosexual male patients in Estonia. Infect Dis. 2018;50:133–9.
Unemo M, Salado-Rasmussen K, Hansen M, Olsen AO, Falk M, Golparian D, et al. Clinical and analytical evaluation of the new Aptima Mycoplasma genitalium assay, with data on M. genitalium prevalence and antimicrobial resistance in M. genitalium in Denmark, Norway and Sweden in 2016. Clin Microbiol Infect. 2018;24:533–9.
Google Scholar
Braam JF, Van Dam AP, Bruisten SM, Van Rooijen MS, de Vries HJC, Schim van der Loeff MF, et al. Macrolide-resistant Mycoplasma genitalium impairs clinical improvement of male urethritis after empirical treatment. Sex Transm Dis. 2021. https://doi.org/10.1097/OLQ.0000000000001591.
Google Scholar
Taylor-Robinson D, Jensen JS. Mycoplasma genitalium: from Chrysalis to multicolored butterfly. Clin Microbiol Rev. 2011;24:498–514.
Google Scholar
Andersen B, Sokolowski I, Ostergaard L, Kjolseth Moller J, Olesen F, Jensen JS. Mycoplasma genitalium: prevalence and behavioural risk factors in the general population. Sex Transm Infect. 2007;83:237–41.
Google Scholar
Gdoura V, Daoudi F, Bouzid F, Ben Salah F, Chaigneau C, Sueur JM, et al. Detection of Chlamydia trachomatis in semen and urethral specimens from male members of infertile couples in Tunisia. Eur J Contracept Reprod Health Care. 2001;6:14–20.
Google Scholar
Kim HJ, Park JK, Park S, Kim YG, Choi H, Ko JI, et al. The prevalence of causative organisms of community-acquired urethritis in an age group at high risk for sexually transmitted infections in Korean Soldiers. J R Army Med Corps. 2017;163:20–2.
Google Scholar
Duron S, Panjo H, Bohet A, Bigaillon C, Sicard S, Bajos N, et al. Prevalence and risk factors of sexually transmitted infections among French service members. Plos ONE. 2018;13:e0195158.
Google Scholar
Trei JS, Canas LC, Gould PL. Reproductive tract complications associated with Chlamydia trachomatis infection in US Air Force males within 4 years of testing. Sex Trans Dis. 2008;35:827–33.
Lesiak-Markowicz I, Schötta A, Stockinger H, Stanek G, Markowicz M. Chlamydia trachomatis serovars in urogenital and ocular samples collected 2014–2017 from Austrian patients. Sci Rep. 2019;4:18327.
European Center for Disease Prevention and Control. Sexually transmitted infections in Europe 2013. Stockholm: ECDC, 2015. htpp://ecdc.europa.eu/en/publications/Publications/sexual-transmitted-infections europe-surveillance-report-2013.pd. Accessed on 10.10.2022.
Discovered on: 2022-11-14 00:00:00
Source: Prevalence of selected sexually transmitted infectious agents in a cohort o…
